SwePub - search: id:"swepub:oai:DiVA.org:liu-19...

Enumeration	Reference	Cover	Find
1.	Yang, Yunlong, et al. (author) Up-to-date molecular medicine strategies for management of ocular surface neovascularization 2023 In: Advanced Drug Delivery Reviews. - : ELSEVIER. - 0169-409X .- 1872-8294. ; 201 Research review (peer-reviewed)abstract Ocular surface neovascularization and its resulting pathological changes significantly alter corneal refraction and obstruct the light path to the retina, and hence is a major cause of vision loss. Various factors such as infection, irritation, trauma, dry eye, and ocular surface surgery trigger neovascularization via angiogenesis and lym-phangiogenesis dependent on VEGF-related and alternative mechanisms. Recent advances in antiangiogenic drugs, nanotechnology, gene therapy, surgical equipment and techniques, animal models, and drug delivery strategies have provided a range of novel therapeutic options for the treatment of ocular surfaceneovascularization. In this review article, we comprehensively discuss the etiology and mechanisms of corneal neovascularization and other types of ocular surface neovascularization, as well as emerging animal models and drug delivery strategies that facilitate its management.

Yang, Yunlong, et al. (author)
Up-to-date molecular medicine strategies for management of ocular surface neovascularization
2023
In: Advanced Drug Delivery Reviews. - : ELSEVIER. - 0169-409X .- 1872-8294. ; 201
Research review (peer-reviewed)abstract
- Ocular surface neovascularization and its resulting pathological changes significantly alter corneal refraction and obstruct the light path to the retina, and hence is a major cause of vision loss. Various factors such as infection, irritation, trauma, dry eye, and ocular surface surgery trigger neovascularization via angiogenesis and lym-phangiogenesis dependent on VEGF-related and alternative mechanisms. Recent advances in antiangiogenic drugs, nanotechnology, gene therapy, surgical equipment and techniques, animal models, and drug delivery strategies have provided a range of novel therapeutic options for the treatment of ocular surfaceneovascularization. In this review article, we comprehensively discuss the etiology and mechanisms of corneal neovascularization and other types of ocular surface neovascularization, as well as emerging animal models and drug delivery strategies that facilitate its management.

Träfflista för sökning "id:"swepub:oai:DiVA.org:liu-198868" "